Kevin is a member of the Life Sciences Health Industry Group, focusing his practice in the area of product liability litigation, primarily on the defense of pharmaceutical and medical device companies in complex actions. He has served on multiple high-profile mass tort trial teams, including the Polypropylene Hernia Mesh Products Liability Litigation, Composix Kugel hernia repair patch litigation, Avaulta transvaginal mesh litigation, Vioxx litigation, Diet Drug litigation, Avandia litigation, Inferior Vena Cava (IVC) Filter litigation, and Infuse Bone Graft litigation.
Experience
Representative matters
Representative matters
Polypropylene Hernia Mesh Products Liability Litigation: Representing C.R. Bard, Inc. and Davol, Inc. in federal multidistrict litigation involving hernia mesh patches, as national counsel and trial team member. Member of the trial team for first three bellwether trials, including the first bellwether trial that resulted in a defense verdict.
Composix Kugel Hernia Repair Patch Litigation: Representing C.R. Bard, Inc. and Davol, Inc. in state coordinated cases and federal multidistrict litigation involving hernia mesh patches, as national counsel and trial team member.
Avaulta Litigation: Representing C.R. Bard, Inc. in state court and federal multidistrict litigation involving transvaginal mesh patches.
Polypropylene Hernia Mesh Products Liability Litigation: Representing C.R. Bard, Inc. and Davol, Inc. in federal multidistrict litigation involving hernia mesh patches, as national counsel and trial team member. Member of the trial team for first three bellwether trials, including the first bellwether trial that resulted in a defense verdict.
Composix Kugel Hernia Repair Patch Litigation: Representing C.R. Bard, Inc. and Davol, Inc. in state coordinated cases and federal multidistrict litigation involving hernia mesh patches, as national counsel and trial team member.
Avaulta Litigation: Representing C.R. Bard, Inc. in state court and federal multidistrict litigation involving transvaginal mesh patches.
Inferior Vena Cava (IVC) Filter Litigation: Representing C. R. Bard, Inc. in litigation involving medical device vascular filters for prevention of life-threatening pulmonary emboli.
Avandia Litigation: Representing GlaxoSmithKline in litigation involving prescription medication for treatment of diabetes.
Infuse Bone Graft: Representing Medtronic, Inc. in litigation involving medical device used for spinal fusion.
Vioxx Litigation: Represented Merck in California coordinated litigation involving prescription pain medication.
Mirapex Litigation: Represented Pfizer Inc. in litigation involving prescription medication for treatment of Parkinson's Disease, as member of national counsel and trial team.
Diet Drug Litigation: Represented Wyeth in cases involving prescription medications for aid in weight loss, as member of multi-firm defense team.
Benzene Litigation: Represented two industry leading manufacturing clients in multiple cases in California involving alleged toxic torts involving benzene.
Alcohol Industry: Advised alcoholic beverage manufacturers on potential product liability litigation as well as the 2025 Surgeon General’s Advisory pertaining to warnings on alcoholic beverages.
Stinson v C. R. Bard (S.D. Ohio) (November 2023): Representing C.R. Bard in the third bellwether trial for the Polypropylene Hernia Mesh Products Liability Litigation MDL. This was another plaintiff selected case, which resulted in a defense verdict on design and punitive damage claims and a plaintiff verdict for $500,000 on the remaining claims.
Milanesi v C.R. Bard, (S.D. Ohio) (April 2022): Representing C.R. Bard in the second bellwether trial for the Polypropylene Hernia Mesh Products Liability Litigation MDL. This was a plaintiff selected case, which resulted in a defense verdict on six of seven claims and plaintiffs’ verdict on the one remaining claim for $255,000.
Johns v. C.R. Bard (S.D. Ohio) (August 2021): Representing C.R. Bard in first "bellwether” trial for the Polypropylene Hernia Mesh Products Liability Litigation MDL, resulting in complete defense verdict.
Scott v. C.R. Bard (Kern County Superior Court)(July 2012): Representing C.R. Bard in the first trial in the country involving transvaginal mesh used for the treatment of pelvic organ prolapse.
Whitfield v. C.R. Bard (D.R.I.)(April 2010): Representing C.R. Bard in first MDL "bellwether” trial involving the Composix Kugel Hernia patch, resulting in complete defense verdict.
Thorpe v. C.R. Bard (D.R.I.)(August 2010): Representing C.R. Bard in the second MDL “bellwether” trial involving the Composix Kugel Hernia patch.
Grossberg v. Merck & Co. (Los Angeles Superior Court) (August 2006): Representing Merck in the first trial in California coordinated Vioxx litigation, resulting in defense verdict, as member of multi-firm trial team.
In re Mirapex Products Liability Litigation (D. Minn.) (July 2008): Representing Pfizer in first MDL "bellwether" trial involving prescription medication Mirapex.
In re: CA Diet Drug Litigation (Los Angeles Superior Court) (November 2005): Representing Wyeth in California-coordinated diet drug litigation resulting in four defense verdicts in a consolidated trial.
Credentials
Education
Education
- University of Notre Dame Law School, 2002, J.D., Member of the National Moot Court Appellate Team
- University of Notre Dame, 1999, B.B.A., Marketing and Computer Applications, cum laude
Professional admissions & qualifications
Professional admissions & qualifications
- California
Court admissions
Court admissions
- U.S. District Court - Central District of California
- U.S. District Court - Eastern District of California
- U.S. District Court - Northern District of California
- U.S. District Court - Southern District of California
Professional affiliations
Professional affiliations
- American Bar Association
- California Bar Association